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Abstract
In 2001, a 71-year old male was admitted to our hospital with unstable angina. The angiography
revealed 2-vessel disease with a 90% stenosis of the proximal LAD. A bare-metal stent was
implanted. Four years later the angiography showed a 80% instent-stenosis in the bare-metal stent
but no progress at the other coronary arteries. A DES was implanted. Again, four years later, the
patient presented with non-ST-elevation myocardial infarction. Angiography showed a 90% instent-
restenosis, again without any progession of coronary artery disease in the other vessels. Again a
DES implanted. Therefore the processes involved in the late instent-stenosis were not influenced
by the antiproliferative agent sirolimus
Case presentation
In April 2001 a 71-year old male (German) was admitted
to our hospital with unstable angina. Blood pressure at
admission was 160/80 mmHg, LDL cholesterol was 127
mg/dl and no diabetes exist. The electrocardiogram
showed persistent atrial fibrillation with negative T-waves
in leads V2-V5. The angiography revealed 2-vessel disease
with a 90% stenosis of the proximal LAD (Figure 1a). A
bare-metal stent (3.0/18 mm) was implanted (Figure 1b).
Aspirin und clopidogrel were prescribed against stent-
thrombosis by the use of bare-metal stent for 4 weeks fol-
lowed by oral anticoagulation with a vitamin-K antago-
nist (INR 2-3, phenprocoumon). Four years later the same
patient was hospitalized once again with stable angina.
Blood pressure was 130/70 mmHg at admission and in
the meanwhile the patient had diabetes. The angiography
showed a 80% instent-stenosis in the bare-metal stent but
no progress at the other coronary arteries (Figure 2a). This
time a sirolimus-eluting stent (CYPHER 3.0/23 mm) was
implanted (Figure 2b). Aspirin, clopidogrel and the same
oral anticoagulation (phenprocoumon) were given for
three months against stent-thrombosis by use of drug-
eluting stent followed by oral anticoagulation alone.
Again, four years later, in February 2009, the patient pre-
sented with non-ST-elevation myocardial infarction.
Blood pressure was 120/80 mmHg at admission and the
patient presented with the same risk factors as prescribed.
Angiography showed a 90% instent-restenosis in the LAD
again without any progession of coronary artery disease in
the other vessels (Figure 3a). Again, a drug-eluting stent
(XIENCE V 3.0/28 mm) implanted (Figure 3b).
Discussion
This case is unusual, because a late instent-stenosis was
observed twice without any difference in the time interval
of the clinical occurrence of the restenosis between bare-
metal and drug-eluting stent [1-3]. Usually restenosis
occurs within 6 months after stent implantation. Thereaf-
ter the annual restenosis rate is only about 1-2%. In this
case, the implantation of a DES did not prolong the time-
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interval until the restenosis became clinically apparent.
Therefore, the processes involved in the late instent-sten-
osis in this patient were not influenced by the antiprolif-
erative agent sirolimus [4,5].
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Angiography after implantation of a bare-metal stent (2001) Figure 1
Angiography after implantation of a bare-metal stent (2001).
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Second instent-stenosis in 2009 Figure 2
Second instent-stenosis in 2009.
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A. Second instent-stenosis in 2009 Figure 3
A. Second instent-stenosis in 2009. b. Final result after PCI with drug-eluting stent in 2009.
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